Plaque Psoriasis trials recruiting in Ohio

All Plaque Psoriasis trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
  NCT07250802 · Phase: Phase 3 · Ages: 4 Years to 17 Years · Sex: All (male and female) · Ohio: Canton, Fairborn, Mayfield Heights
• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT06979453 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Ohio: Canton, Lorain, Mayfield Heights
• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
  NCT07474792 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Ohio: Bexley
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · Ohio: Bexley, Canal Winchester, Canton, Fairborn
• Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
  NCT04036188 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Fairborn